Free Trial

Capstone Therapeutics (CAPS) Earnings Date, Estimates & Call Transcripts

Capstone Therapeutics logo
$1.10 +0.09 (+8.91%)
As of 04:00 PM Eastern

Capstone Therapeutics Earnings Summary

Capstone Therapeutics released Q2 2025 earnings on August 15, 2025, reporting an EPS of -$0.13. Quarterly revenue was reported to be $12.85 million. Capstone Therapeutics currently has a trailing EPS of $0.00

Actual Revenue
(Aug. 15)
$12.85M

Q2 2025 Earnings Resources

Get Capstone Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Capstone Therapeutics and other key companies, straight to your inbox.

Sign Up

Capstone Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/15/2025Q2 2025--$0.13--$0.13-$12.85M


This page (NASDAQ:CAPS) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners